BVT Knock-Out PGR/ DE000VD35UK8 /
| 2024-05-21 9:36:21 PM | Chg.+0.150 | Bid10:00:36 PM | Ask10:00:36 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.450EUR | +50.00% | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 205.39 USD | 2078-12-31 | Call |
GlobeNewswire
10:30 PM
Team, Inc. Showcases Strategic Vision With New Investor Presentation and Recording
GlobeNewswire
10:15 PM
Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the A...
GlobeNewswire
10:06 PM
Second Snoqualmie Casino Guest Hits $1M Jackpot on Light & Wonder’s 5 TREASURES EXPLOSION™ Slot Mach...
GlobeNewswire
10:00 PM
Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update
GlobeNewswire
3:00 PM
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data ...
GlobeNewswire
2:30 PM
Positive Statistically Significant Phase 2 Clinical Trial Results of Biodexa’s Newly-licensed eRapa™...
GlobeNewswire
2:00 PM
Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study f...
GlobeNewswire
05-20
Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...
GlobeNewswire
05-20
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau)...
GlobeNewswire
05-20
Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Tria...
GlobeNewswire
05-20
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...
GlobeNewswire
05-16
BMW unveils The BMW XM Mystique Allure, a one-of-a-kind luxury vehicle inspired by the iconic superm...
GlobeNewswire
05-15
Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III P...
GlobeNewswire
05-14
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment...
GlobeNewswire
05-13
Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...
GlobeNewswire
05-13
BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...
GlobeNewswire
05-13
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
GlobeNewswire
05-09
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...
GlobeNewswire
05-09
Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...
GlobeNewswire
05-08
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...
